Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement

计划入组 18 人 · 首次发布于 2026 年 9 月 8 日

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

计划入组 60 人 · 首次发布于 2019 年 9 月 27 日

Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases

计划入组 2,000 人 · 首次发布于 2021 年 12 月 29 日

2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate

C₉H₁₆N₃O₁₃P₃

2'-deoxyuridine 5'-alpha,beta-imido-diphosphate

C₉H₁₅N₃O₁₀P₂

Novel Combination Therapy Trial Launches for Inflammatory Diseases with HudsonAlpha's Genomic Support

Genetic Study Reveals One-Way Link Between Cardiovascular Disease and Psoriasis Risk

CRBN Gene Mutations Show Variable Impact on Myeloma Drug Response, Enabling Precision Treatment Selection